Stockreport

Structure Therapeutics to Participate in the Jefferies London Healthcare Conference

Structure Therapeutics Inc.  (GPCR) 
PDF SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral sm [Read more]